Profile for Lipocine Inc. (LPCN)
« Back to company indexLPCN Chatter Timeline
Stock Ticker for LPCN
Most Active Tweeters for LPCN
| User | Tweets |
|---|---|
| @keitrader | 4 |
| @GNWLive | 3 |
| @stockboardinc | 3 |
| @confcalltran | 3 |
| @vanjohn10 | 3 |
Recent Tweets for LPCN
 |
@TheMarketsDaily Somewhat Positive News Coverage Somewhat Unlikely to Impact Lipocine $LPCN Share Price https://t.co/VrOZandxAg September 25th 2017, 5:09pm |
 |
@PiggyBankPeople RT @ZacksAwareness: Patent Board Motions Decision a Positive https://t.co/HS13tEFw54 $LPCN @vanjohn10 #biotech https://t.co/vI5YpBOjki September 25th 2017, 1:09pm |
 |
@InstitutionalZC Patent Board Motions Decision a Positive https://t.co/xM5AkghzD4 $LPCN @vanjohn10 #biotech https://t.co/KsOQ8O8zhs September 25th 2017, 12:09pm |
 |
@ahighelevation Patent Board Motions Decision a Positive https://t.co/nOUfAo6bj0 $LPCN @vanjohn10 #biotech https://t.co/t4Rx45whCC September 25th 2017, 12:09pm |
 |
@ZacksAwareness Patent Board Motions Decision a Positive https://t.co/HS13tEFw54 $LPCN @vanjohn10 #biotech https://t.co/vI5YpBOjki September 25th 2017, 12:09pm |
 |
@RoboSchmobo RT @VCapital_invest: Patent Board Motions Decision a Positive $LPCN @vanjohn10 #biotech https://t.co/pYyQZ62Prj https://t.co/mP0Lv5bT1m September 25th 2017, 12:09pm |
 |
@cmiller1225 RT @tzack16: Patent Board Motions Decision a Positive https://t.co/qALWcjuA5V $LPCN @vanjohn10 #biotech https://t.co/PWBoPeR53w September 25th 2017, 12:09pm |
 |
@tzack16 Patent Board Motions Decision a Positive https://t.co/qALWcjuA5V $LPCN @vanjohn10 #biotech https://t.co/PWBoPeR53w September 25th 2017, 12:09pm |
 |
@zackcappsocial Patent Board Motions Decision a Positive https://t.co/dnaY7SXzJc $LPCN @vanjohn10 #biotech https://t.co/LJ3rs65Zzt September 25th 2017, 12:09pm |
 |
@VCapital_invest Patent Board Motions Decision a Positive $LPCN @vanjohn10 #biotech https://t.co/pYyQZ62Prj https://t.co/mP0Lv5bT1m September 25th 2017, 11:09am |
 |
@jimmiebjorling Patent Board Motions Decision a Positive $LPCN @vanjohn10 #biotech https://t.co/k2DSLLLGrh https://t.co/jNau44FJSN September 25th 2017, 11:09am |
 |
@confcalltran Lipocine: Men'S Health Franchise Testosterone Replacement Therapy (“Trt”) Women'S Health Preter https://t.co/wcgJV0xXC7 $LPCN September 25th 2017, 8:09am |
 |
@WKRBNews Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/s0HjsHLOKO September 24th 2017, 12:09pm |
 |
@dailymailtimes Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/tLICpkE5FO September 24th 2017, 12:09pm |
 |
@midetimes Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/25VxyWDuJX September 24th 2017, 12:09pm |
 |
@dailypoliticaln Lipocine Inc. $LPCN Shares Sold by VHCP Management II LLC https://t.co/6MTV8uA86j September 24th 2017, 12:09pm |
 |
@TickerReport Lipocine Inc. $LPCN Shares Bought by Federated Investors Inc. PA https://t.co/lEixFXAm1M September 23rd 2017, 5:09am |
 |
@emq_news Lipocine Inc. $LPCN Shares Bought by Federated Investors Inc. PA https://t.co/5Taa2Yliga September 23rd 2017, 5:09am |
|
@TickerReport Lipocine Inc. $LPCN Shares Bought by Federated Investors Inc. PA https://t.co/790n2EJ53Q September 23rd 2017, 5:09am |
 |
@ZacksSmallCap $LPCN Advisory Committee Required and USPTO Issues Motion for Tlando @vanjohn10 https://t.co/2duKVg9Tfn September 22nd 2017, 4:09pm |
 |
@FDAadcomm Lipocine says it will have an FDA adcomm for it’s oral testosterone, TLANDO. Date is TBD. PDUFA in Feb $LPCN #BRUDAC https://t.co/h80k9KOmlN September 21st 2017, 6:09pm |
 |
@keitrader RT @SolarMelt: $LPCN Improvements over current treatments: no BlackBox warning, no more messy gels, no painful injections, no more risk of… September 21st 2017, 5:09pm |
|
@keitrader RT @SolarMelt: $LPCN TLANDO appears poised to dominate a $2B US market, but IP issues remain. September 21st 2017, 5:09pm |
 |
@BiotechPhD Hey dummy - Are you still losing money in the stock market? $lpcn https://t.co/x1pkgGmOTQ September 21st 2017, 1:09pm |
 |
@LifeSciAdvisors Lipocine $LPCN: Announces Motions Decision by USPTO in Interference Against Clarus https://t.co/NtwGcY60WW September 21st 2017, 11:09am |
 |
@7LadyQ $LPCN PTAB ruling bolsters Lipocine's position in patent dispute with Clarus Therapeutics; shares ahead 2% September 21st 2017, 11:09am |
 |
@MarketCurrents PTAB ruling bolsters Lipocine's position in patent dispute with Clarus Therapeutics; shares ahead 2% https://t.co/qvS92a8JKc $LPCN September 21st 2017, 10:09am |
 |
@SEEKINGALPHA_FS PTAB ruling bolsters Lipocine's position in patent dispute with Clarus Therapeutics; shares ahead 2% https://t.co/QXrkmIznr9 $LPCN September 21st 2017, 10:09am |
 |
@Briefingcom $LPCN: Lipocine announces motions decision by USPTO in interference against Clarus; the PTAB granted Lipocine’s... https://t.co/2zJ6euvd3G September 21st 2017, 10:09am |
 |
@vanjohn10 $LPCN announces motions decision by USPTO in interference against Clarus. https://t.co/OdVope5VEB September 21st 2017, 9:09am |
 |
@SolarMelt $LPCN TLANDO appears poised to dominate a $2B US market, but IP issues remain. September 21st 2017, 9:09am |
|
@SolarMelt $LPCN Improvements over current treatments: no BlackBox warning, no more messy gels, no painful injections, no more risk of transference. September 21st 2017, 9:09am |
|
@SolarMelt $LPCN An Advisory Committee will review TLANDO, aka LPCN-1021, for Hypogonadism sometime before the PDUFA date of FEB 8th, 2018. September 21st 2017, 9:09am |
 |
@Mahmissa RT @confcalltran: Lipocine Announces Motions Decision By Uspto In Interference Against Clarus https://t.co/qC1RZFRVgy $LPCN September 21st 2017, 9:09am |
 |
@ProTradersNews $LPCN: Lipocine Announces Motions Decision by USPTO in Interference …: https://t.co/RoAui4MzaC September 21st 2017, 8:09am |
 |
@StockTexts $LPCN Lipocine Announces Motions Decision by USPTO in Interference Against Clarus Nasdaq:LPCN https://t.co/DvjvStrSyB September 21st 2017, 8:09am |
|
@confcalltran Lipocine Announces Motions Decision By Uspto In Interference Against Clarus https://t.co/qC1RZFRVgy $LPCN September 21st 2017, 8:09am |
 |
@stockboardinc $LPCN Lipocine Announces Motions Decision by USPTO in Interference Against Clarus... - https://t.co/BrT1hfnyj5 September 21st 2017, 8:09am |
 |
@stocknewsdotcom $LPCN Announces motions decision by USPTO in interference against Clarus; the PTAB granted Lipocine’s motion to … https://t.co/0mcTMmFnJD September 21st 2017, 8:09am |
 |
@GNWLive Lipocine Announces Motions Decision by USPTO in Interference Against Clarus $LPCN https://t.co/O3CQRsBlgY September 21st 2017, 8:09am |
 |
@marketexclusive LIPOCINE INC. (NASDAQ:LPCN) Files An 8-K Financial Statements and Exhibits https://t.co/KrTt3ECDuh $LPCN September 20th 2017, 8:09pm |
 |
@MaisaCorp $LPCN said FDA Panel meeting date has not been set but will occur prior to the prescription drug user fee act goal date of Feb. 8, 2018 September 20th 2017, 3:09pm |
 |
@StockNewsNow $LPCN Lipocine Announces FDA Advisory Committee Meeting for TLANDO™ https://t.co/bmnFh7fhFK September 20th 2017, 1:09pm |
|
@SEEKINGALPHA_FS FDA advisory committee to review Lipocine's application for TRT candidate TLANDO; shares up 2% https://t.co/98aTZlFngo $LPCN September 20th 2017, 12:09pm |
|
@MarketCurrents FDA advisory committee to review Lipocine's application for TRT candidate TLANDO; shares up 2% https://t.co/sLBMZMwaWW $LPCN September 20th 2017, 12:09pm |
|
@LifeSciAdvisors Lipocine $LPCN: Announces FDA Advisory Committee Meeting for TLANDO™ https://t.co/NtwGcY60WW September 20th 2017, 10:09am |
|
@Briefingcom $LPCN: Lipocine announces that the Bone, Reproductive and Urologic Drugs Advisory Committee of the FDA plans to... https://t.co/f7I2zk00ou September 20th 2017, 10:09am |
 |
@tsilver_apex @BioStocks Quick correction: $LPCN September 20th 2017, 8:09am |
 |
@NewsToDesk $LPCN: Lipocine Announces FDA Advisory Committee Meeting for TLANDO™: https://t.co/YQnkFjDnxQ September 20th 2017, 8:09am |
 |
@bkfViking123 $lpcn risk reward is huge ... end game ..... long September 20th 2017, 8:09am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.